Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genetic instability of the 2.3Col1a1-Cre transgenic line reveals a threshold for leukemogenesis in a model of osteoblast-induced acute myeloid leukemia
    Meeting Abstract

    Mosialou, I.; Cuesta-Dominiguez, A.; Teruya-Feldstein, J.; Berman, E.; Kousteni, S.
    Journal of Bone and Mineral Research (2017)

    Fulltext@MSK | Save
  • Armored CAR T cells genetically modified to secrete IL-12 show enhanced efficacy and overcome a hostile tumor microenvironment in mouse ovarian peritoneal carcinomatosis
    Meeting Abstract

    Yeku, O.; Purdon, T.; Spriggs, D.; Brentjens, R.
    Cancer Immunology Research (2017)

    Fulltext@MSK | Save
  • Single-agent dabrafenib for intracranial BRAF(V600E)-mutated histiocytosis
    Meeting Abstract

    Bhatia, A.; Ulaner, G.; Rampal, R.; Hyman, D.; Abdel-Wahab, O.; Durham, B.; Hajdenberg, J.; Ganzel, C.; Diamond, E.
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Phase 2 study of selinexor in patients with myelodysplastic syndromes refractory to hypomethylating agents: Interim report
    Meeting Abstract

    Klimek, V. M.; Coleman, M.; Alvarez, K.; Sen, F.; Pichardo, J.; Kashyap, T.; Klebanov, B.
    Leukemia Research (2017)

    Fulltext@MSK | Save
  • Symptom burden of patients with newly diagnosed myelodysplastic syndromes (MDS) receiving outpatient cancer care
    Meeting Abstract

    Desai, A. V.; Goldberg, J. I.; Anderson, K.; Ranaghan, C.; O'shea, D.; Chow, K.; Kramer, D.; Rawlins, R.; Wan, P. J.; Klimek, V. M.; more...
    Leukemia Research (2017)

    Fulltext@MSK | Save
  • Impact of early integration of palliative care on health care proxy (HCP) documentation by patients with myelodysplastic syndromes (MDS)
    Meeting Abstract

    Desai, A. V.; Chow, K.; Wan, P. J.; O'shea, D.; Ranaghan, C.; Anderson, K.; Kramer, D.; Goldberg, J. I.; Rawlins, R.; Koczela, E.; more...
    Leukemia Research (2017)

    Fulltext@MSK | Save
  • Robust patient-derived xenografts (PDX) capture the disease fidelity of chronic myelomonocytic leukemia (CMML) and juvenile myelomonocytic leukemia (JMML)
    Meeting Abstract

    Balasis, M. E.; Yoshimi, A.; Vedder, A.; Feldman, K.; Ma, Y.; Zhang, H.; Lee, S. C. W.; Letson, C.; Niyongere, S.; Lu, S. X.; more...
    Leukemia Research (2017)

    Fulltext@MSK | Save
  • An analysis of the transcriptional response of myelodysplastic syndrome stem cells to therapy at single-cell resolution
    Meeting Abstract

    Chung, S.; Vijay, P.; Klimek, V.; Mason, C.; Park, C.
    Leukemia Research (2017)

    Fulltext@MSK | Save
  • Enasidenib (AG-221), a selective oral inhibitor of mutant isocitrate dehydrogenase 2 (IDH2) enzyme, in patients with myelodysplastic syndromes (MDS)
    Meeting Abstract

    Stein, E. M.; Fathi, A. T.; DiNardo, C. D.; Pollyea, D. A.; Swords, R. T.; Roboz, G. J.; Collins, R.; Sekeres, M. A.; Stone, R. M.; Attar, E. C.; more...
    Leukemia Research (2017)

    Fulltext@MSK | Save
  • Characterization of novel oral splicing modulator, H3B-8800, identifies the mechanistic basis for its preferential lethality towards spliceosome-mutant myeloid malignancy models
    Meeting Abstract

    Buonamici, S.; Yoshimi, A.; Thomas, M.; Seiler, M.; Chan, B.; Csibi, A.; Fekkes, P.; Klimek, V.; Kumar, P.; Lee, S. C. W.; more...
    Leukemia Research (2017)

    Fulltext@MSK | Save